Secondly, phosphodiesterase 4 (PDE4) aggravates the inflammatory response in NASH by degrading cyclic adenosine monophosphate (cAMP) and disrupting intracellular signaling, which further elevates IL-6 expression levels (105). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.